Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 420 Precursor Cell Lymphoblastic Leukemia-Lymphoma 126 Neoplasms, Plasma Cell 74 Recurrence 70 Lymphoma 57 Leukemia 54 Neoplasms 46 Immunoglobulin Light-chain Amyloidosis 38 Burkitt Lymphoma 37 Vomiting 36 Lymphoma, Mantle-Cell 32 Lymphoma, Large B-Cell, Diffuse 31 Nausea 29 Lymphoma, Non-Hodgkin 28 Breast Neoplasms 22 Waldenstrom Macroglobulinemia 21 Lymphoma, Follicular 21 Hodgkin Disease 21 Leukemia, Lymphocytic, Chronic, B-Cell 20 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17 Neoplasm Metastasis 17 Prostatic Neoplasms 16 Lymphoma, Extranodal NK-T-Cell 16 Amyloidosis 16 Leukemia, Myeloid, Acute 15 Smoldering Multiple Myeloma 14 Lymphoma, B-Cell, Marginal Zone 13 Lung Neoplasms 11 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, B-Cell 10

Interventions

Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1 Radiotherapy 1 Radiomics 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Hydrocortisone 1 Human Growth Hormone 1 Diazoxide 1 Dexmedetomidine 1 Dexamethasone 1 Biomarkers 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pituitary Diseases × Dexamethasone × Clear all

NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed

43 enrolled 8 charts

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡